Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-03-04 @ 2:54 PM
Study NCT ID:
NCT04609293
Status:
UNKNOWN
Last Update Posted:
2020-10-30
First Post:
2020-10-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Study of Camrelizumab Combined With Apatinib and Hyperfractionated Radiotherapy for Renal Cell Carcinoma
Sponsor:
Organization: